CLNH Insider Trading Activity and SEC Form 4 Filings
CLNH insider trading summary
No open-market insider purchases or sales of Clinigence Holdings, Inc. (CLNH) have been reported on SEC Form 4 in the past 12 months.
Latest CLNH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 12, 2020 | David Meiri | Director | Buy | $634.9M (31,746 @ $20000.00) |
| Aug 12, 2020 | Terence Martin Breslin | Director | Buy | $634.9M (31,746 @ $20000.00) |
| Aug 12, 2020 | John J Waters | Director | Buy | $634.9M (31,746 @ $20000.00) |
| Aug 12, 2020 | Mitchell Creem | Director | Buy | $634.9M (31,746 @ $20000.00) |
| Jul 13, 2020 | Jacob Margolin | Director | Buy | $41.06B (228,346 @ $179800.00) |
| Jun 30, 2020 | Lawrence Schimmel | Chief Executive Officer | Buy | $2.91B (44,828 @ $65000.00) |
| Jun 30, 2020 | Jacob Margolin | Director | Buy | $1.40B (31,034 @ $45000.00) |
| May 27, 2010 | Robert A Meister | Director | Sell | $1K (5,900 @ $0.23) |
| May 27, 2010 | Robert A Meister | Director | Sell | $3K (15,100 @ $0.23) |
| May 27, 2010 | Robert A Meister | Director | Sell | $983 (4,200 @ $0.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.